Therapeutic targets in pancreatic cancer

Next Thursday 19th March, Davide Melisi, Instructor Department of Gastrointestinal Medical Oncology, Anderson Cancer Center, University of Texas, will give the next conference at 9:30 am in the Conference room, 2nd floor, Vall d’Hebron Research Institute:

Smad-dependent and Smad-independent pathways in TGF-ß signaling as therapeutic targets in pancreatic cancer

Related Posts

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.